scispace - formally typeset
A

Arja Reinikainen

Researcher at Åbo Akademi University

Publications -  5
Citations -  616

Arja Reinikainen is an academic researcher from Åbo Akademi University. The author has contributed to research in topics: Signal transduction & ABL. The author has an hindex of 5, co-authored 5 publications receiving 572 citations. Previous affiliations of Arja Reinikainen include University of Turku.

Papers
More filters
Journal ArticleDOI

PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells.

TL;DR: It is shown that PARP-14 plays a fundamental role mediating protection against apoptosis in IL-4-treated B cells, including that after DNA damage, and mediates IL- 4 effects on the levels of gene products that regulate cell survival, proliferation, and lymphomagenesis.
Journal ArticleDOI

Autoimmune regulator induced changes in the gene expression profile of human monocyte-dendritic cell-lineage.

TL;DR: The findings suggest that the role of AIRE in the DCs differs from its function in the thymus, and the ERK signal transduction pathway is identified as a candidate for mediating the signal that results in the altered expression profile.
Journal ArticleDOI

Reduced oncogenicity of p190 Bcr/Abl F-actin-binding domain mutants.

TL;DR: Results show that the actin-binding domain of Abl enhances leukemia development but does not appear to be an absolute requirement for leukemogenesis.
Journal ArticleDOI

Up‐Regulation of Host Cell Genes during Interferon‐γ-Induced Persistent Chlamydia pneumoniae Infection in HL Cells

TL;DR: Results suggest that, during persistent infection, C. pneumoniae reprograms the host transcriptional machinery that regulates a variety of cellular processes, including adhesion, regulation of the cell cycle, growth, and inflammatory response, all of which might play important roles in the pathogenesis of persistent C.neumoniae infection.